DOW
Dow Inc.$33.72
Buy
Target $47.06
Report: Mar 08, 2026Basic Materials • Chemicals • Cyclical OperatorSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$33.72+39.6%
Rec: BuyConviction: Medium
Entry Target
$33.72
(0% above current)
Fair Value
$47.06
(40% above current)
Stop Loss
$20.00
(41% below current)
Position Size
Half
Time Horizon
Transitional (12-24 Months)
Key Metrics
Live Snapshot
Market Data
52 Week High$42.74
52 Week Low$20.40
Avg. 3 Month Volume13.96M
Efficiency
LTM Gross Margin6.3%
LTM EBITDA Margin2.5%
LTM EBIT Margin-4.6%
LTM Operating Margin-3.9%
LTM ROA-4.4%
LTM ROE-15.5%
LTM ROIC-3.3%
LTM ROCE-3.8%
Capital Structure
Market Cap (MM)$29.9B
Enterprise Value (MM)$45.7B
Shares Outstanding718.20M
Total Debt (MM)$19.60B
Cash & Equivalents (MM)$3.82B
LTM Net Debt (MM)$15.78B
LTM Net Debt/EBITDA15.6x
Growth
TTM Rev. Growth-7.0%
Last 3-Yr Rev. CAGR-11.1%
Last 3-Yr EBITDA CAGR-52.6%
Last 3-Yr EPS CAGRN/A
Valuation
Street Target Price$28.86
LTM EV/Revenue1.1x
LTM EV/Gross Profit18.0x
LTM EV/EBIT-25.0x
LTM EV/EBITDA45.3x
LTM P/E-11.4x
LTM EV/FCF-27.8x
LTM P/FCF-18.2x
LTM P/TB0.6x
LTM P/B1.9x
Dividend Yield5.0%
Payout Ratio-56.6%
Executive SummarySituation: Current price is $33.72 versus fair value $47.06 (39.6% expected return), and valuation confidence is stable. Debate: Bull case depends on Execution of the Transform to Outperform program. Bear case centers on Lower-for-longer cyclical downturn. Conclusion: Recommendation is Buy with Half sizing and Transitional (12-24 Months) horizon.
Bull Case
1. Internal self-help through the $2 billion EBITDA Transform to Outperform program provides a clear earnings bridge regardless of macro recovery. 2. Massive supply-side discipline in Europe and North America is tightening the market for the next upcycle. 3. Valuation at 1.5x P/B and a 5.27% dividend yield offers a significant margin of safety at the cyclical trough.
Bear Case
1. A protracted bottom in the chemical cycle driven by persistent Chinese oversupply could delay margin recovery indefinitely. 2. Unquantified PFAS litigation liabilities (15,220 active lawsuits) pose a long-term threat to the balance sheet. 3. High leverage (12.4x Net Debt/EBITDA) limits financial flexibility during the trough.
Key Catalysts
Mid-Term (6-18 months)Impact: Critical
Execution of the Transform to Outperform program. This program targets a $2 billion EBITDA uplift by 2028 through radical simplification and...
Mid-Term (6-18 months)Impact: High
Sadara JV debt refinancing. The mid-2026 refinancing of the Sadara joint venture debt is a key hurdle. A successful resolution without signi...
Long-Term (18+ months)Impact: Moderate
European asset rationalization. The shutdown of high-cost assets in Germany and the UK will structurally improve Dow's margin profile by rem...
Primary Risks
Concern: High
Lower-for-longer cyclical downturn. A sustained global recession or continued oversupply from China could keep chemical spreads at trough le...
Concern: Medium
PFAS Litigation (AFFF MDL 2873). Unquantified liabilities from 15,220 active lawsuits related to PFAS could lead to massive settlements that...
Concern: High
Balance sheet leverage and interest coverage. With net leverage at 12.4x and interest coverage at -2.1x, the company has limited room for fu...
Recent Activity
2026-03-04Analyst Target
+5.20%Firm: KeyBanc Analyst: Aleksey Yefremov Price Target: $38.00 Price When Posted: $30.74 Implied Upside: +23.6%
2026-02-03SEC Filing (8-K)
+5.57%Dow Inc. files 8-K incorporating 2025 10-K exhibit.
2025-10-23SEC Filing (8-K)
+12.95%Dow Inc. reports Q3 2025 financial results with net sales of $10.0 billion, down 8% year-over-year, and GAAP net income of $124 million.
2025-07-24SEC Filing (8-K)
-17.45%Dow Inc. reports Q2 2025 financial results with net sales of $10.1 billion, down 7% year-over-year, and GAAP net loss of $801 million.
2025-07-08SEC Filing (8-K)
+5.75%Dow Inc. announces shutdown of three European upstream assets and additional restructuring.
Valuation Table
9.4/10Decision Grade
Scenario Range
$27
Bear
$66
Base
$100
Bull
$34